Answers are grounded in this paper and cite their sources.
Delivering potent, stable, targeted and in vivo efficacious antibody–drug conjugates (ADCs) using pyridazinedione functional disulfide re-bridging reagents.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: